Qi, X., Li, F., Wu, Y., Cheng, C., Han, P., Wang, J., & Yang, X. (2019). Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity. Nature Portfolio.
Cita Chicago Style (17a ed.)Qi, Xinyue, Fanlin Li, Yi Wu, Chen Cheng, Ping Han, Jieyi Wang, y Xuanming Yang. Optimization of 4-1BB Antibody for Cancer Immunotherapy by Balancing Agonistic Strength with FcγR Affinity. Nature Portfolio, 2019.
Cita MLA (8a ed.)Qi, Xinyue, et al. Optimization of 4-1BB Antibody for Cancer Immunotherapy by Balancing Agonistic Strength with FcγR Affinity. Nature Portfolio, 2019.
Precaución: Estas citas no son 100% exactas.